FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Part of paid clinical trials in Los Altos, California.
- Sponsor
- xCures
- Study ID
- NCT06539169
- Status
- Recruiting
Conditions
- Alpha-Thalassemia
- Amyloidosis
- Amyotrophic Lateral Sclerosis
- Beta-Thalassemia
- Creutzfeld-Jakob Disease
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Early-Onset Alzheimer Disease
- Ehlers-Danlos Syndrome
- GM1 Gangliosidosis
- Gaucher Disease
- Huntington Disease
- Myasthenia Gravis
- Pompe Disease
- Rare Diseases
- Sickle Cell Disease
- Transthyretin Amyloid Cardiomyopathy
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
FLOWER is a completely virtual, nationwide, real-world observational study to collect, annotate, standardize, and report clinical data for rare diseases. Patients participate in the study by electronic consent (eConsent) and sign a medical records release to permit data collection. Medical records are accessed from institutions directly via eFax or paper fax, online from patient electronic medical record (EMR) portals, direct from DNA/RNA sequencing and molecular profiling vendors, and via electronic health information exchanges. Patients and their treating physicians may also optionally provide medical records. Medical records are received in or converted to electronic/digitized formats (CCDA, FHIR, PDF), sorted by medical record type (clinic visit, in-patient hospital, out-patient clinic, infusion and out-patient pharmacies, etc.) and made machine-readable to support data annotation, full text searches, and natural language processing (NLP) algorithms to further facilitate feature identification.
Key Dates
- Start date
- Jun 10, 2024
- Status verified
- Aug 2024
- Primary completion
- Jun 10, 2026
- Completion
- Jun 10, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Overall Survival (OS) [ Time Frame: 5 Years ]
Central Contacts
- Mark Shapiro, MS707-641-4475
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| xCures | Los Altos | California | 94022 |
Find similar trials in Los Altos, CA
Related Studies
- Pompe Disease Registry ProtocolRecruiting · Genzyme, a Sanofi Company · Birmingham, Alabama
- International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registryRecruiting · Genzyme, a Sanofi Company · Phoenix, Arizona
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With TetraplegiaRecruiting · Leigh R. Hochberg, MD, PhD. · Sacramento, California